Cargando…
Recent advances in supramolecular antidotes
Poisons always have fascinated humankind. Initially considered as deleterious or hazardous substances, the modern era has witnessed the controlled utilization of dangerous poisons in medicine and cosmetics. Simultaneously, antidotes have become crucial as reversal agents to counteract the effects of...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738896/ https://www.ncbi.nlm.nih.gov/pubmed/33391548 http://dx.doi.org/10.7150/thno.53459 |
_version_ | 1783623220846395392 |
---|---|
author | Yin, Hang Zhang, Xiangjun Wei, Jianwen Lu, Siyu Bardelang, David Wang, Ruibing |
author_facet | Yin, Hang Zhang, Xiangjun Wei, Jianwen Lu, Siyu Bardelang, David Wang, Ruibing |
author_sort | Yin, Hang |
collection | PubMed |
description | Poisons always have fascinated humankind. Initially considered as deleterious or hazardous substances, the modern era has witnessed the controlled utilization of dangerous poisons in medicine and cosmetics. Simultaneously, antidotes have become crucial as reversal agents to counteract the effects of a poison, and they are also used today to positively cancel the benefits of a poison after use. Currently, the majority of poisons are composed of small molecules. This review focuses on recent developments to reverse or prevent toxic effects of poisons by encapsulation in host molecules. Cyclodextrins, cucurbiturils, acyclic cucurbituril derivatives, calixarenes, and pillararenes, have been reported to largely impact the effects of toxic compounds, thus extending the current paradigm of small molecule antidotes by adding a new family of macrocyclic compounds to the current arsenal of antidotes. Along this line of research, endogenous "harmful" species are also sequestered by one or more of these supramolecular host molecules, expanding the potential of supramolecular antidotes to diverse therapeutic areas. |
format | Online Article Text |
id | pubmed-7738896 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-77388962021-01-01 Recent advances in supramolecular antidotes Yin, Hang Zhang, Xiangjun Wei, Jianwen Lu, Siyu Bardelang, David Wang, Ruibing Theranostics Review Poisons always have fascinated humankind. Initially considered as deleterious or hazardous substances, the modern era has witnessed the controlled utilization of dangerous poisons in medicine and cosmetics. Simultaneously, antidotes have become crucial as reversal agents to counteract the effects of a poison, and they are also used today to positively cancel the benefits of a poison after use. Currently, the majority of poisons are composed of small molecules. This review focuses on recent developments to reverse or prevent toxic effects of poisons by encapsulation in host molecules. Cyclodextrins, cucurbiturils, acyclic cucurbituril derivatives, calixarenes, and pillararenes, have been reported to largely impact the effects of toxic compounds, thus extending the current paradigm of small molecule antidotes by adding a new family of macrocyclic compounds to the current arsenal of antidotes. Along this line of research, endogenous "harmful" species are also sequestered by one or more of these supramolecular host molecules, expanding the potential of supramolecular antidotes to diverse therapeutic areas. Ivyspring International Publisher 2021-01-01 /pmc/articles/PMC7738896/ /pubmed/33391548 http://dx.doi.org/10.7150/thno.53459 Text en © The author(s) This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. |
spellingShingle | Review Yin, Hang Zhang, Xiangjun Wei, Jianwen Lu, Siyu Bardelang, David Wang, Ruibing Recent advances in supramolecular antidotes |
title | Recent advances in supramolecular antidotes |
title_full | Recent advances in supramolecular antidotes |
title_fullStr | Recent advances in supramolecular antidotes |
title_full_unstemmed | Recent advances in supramolecular antidotes |
title_short | Recent advances in supramolecular antidotes |
title_sort | recent advances in supramolecular antidotes |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738896/ https://www.ncbi.nlm.nih.gov/pubmed/33391548 http://dx.doi.org/10.7150/thno.53459 |
work_keys_str_mv | AT yinhang recentadvancesinsupramolecularantidotes AT zhangxiangjun recentadvancesinsupramolecularantidotes AT weijianwen recentadvancesinsupramolecularantidotes AT lusiyu recentadvancesinsupramolecularantidotes AT bardelangdavid recentadvancesinsupramolecularantidotes AT wangruibing recentadvancesinsupramolecularantidotes |